{"id":"https://openalex.org/W2247490335","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","title":"A phase II study of ixabepilone (BMS 247550) in metastatic renal cell carcinoma","display_name":"A phase II study of ixabepilone (BMS 247550) in metastatic renal cell carcinoma","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2247490335","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","mag":"2247490335"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.14646","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036138286","display_name":"Edwin M. Posadas","orcid":"https://orcid.org/0000-0001-8649-1346","observed_orcids":["https://orcid.org/0000-0001-8649-1346"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. M. Posadas","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083194731","display_name":"Samir D. Undevia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Undevia","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069613777","display_name":"Alexander Dimitrios Colevas","orcid":"https://orcid.org/0000-0003-3849-4264","observed_orcids":["https://orcid.org/0000-0003-3849-4264"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. D. Colevas","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012778198","display_name":"Elizabeth Manchen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Manchen","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063904421","display_name":"Everett E. Vokes","orcid":"https://orcid.org/0000-0002-8645-8068","observed_orcids":["https://orcid.org/0000-0002-8645-8068"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. E. Vokes","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088131964","display_name":"Walter Michael Stadler","orcid":"https://orcid.org/0000-0002-0435-2527","observed_orcids":["https://orcid.org/0000-0002-0435-2527"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. M. Stadler","raw_affiliation_strings":["University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"14646","last_page":"14646"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ixabepilone","display_name":"ixabepilone","score":1.0},{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/epothilone-analogs","display_name":"epothilone analogs","score":0.8450000286102295},{"id":"https://openalex.org/keywords/microtubule-stabilizers","display_name":"microtubule stabilizers","score":0.972000002861023},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.8830000162124634},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.36899998784065247},{"id":"https://openalex.org/keywords/lymphopenia","display_name":"lymphopenia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/neuropathy","display_name":"neuropathy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.7870000004768372},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.5189999938011169},{"id":"https://openalex.org/keywords/vhl-mutation","display_name":"VHL mutation","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9035132527351379},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6928834915161133},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6444847583770752},{"id":"https://openalex.org/C2779194965","wikidata":"https://www.wikidata.org/wiki/Q11711607","display_name":"Ixabepilone","level":5,"score":0.6139124035835266},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5534034371376038},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5505844950675964},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5373837351799011},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5044673681259155},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.45975470542907715},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.45311203598976135},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.45048072934150696},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4430393576622009},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43213149905204773},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4045217037200928},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.393730103969574},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.33964473009109497},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.32468461990356445},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2607172727584839},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2112642228603363},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.18589726090431213}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.14646","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.14646","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2259820675","https://openalex.org/W2151830327","https://openalex.org/W2287104963","https://openalex.org/W2035908704","https://openalex.org/W2244569118","https://openalex.org/W177209949","https://openalex.org/W2062399327","https://openalex.org/W2733391944","https://openalex.org/W2027040460","https://openalex.org/W2245624988"],"abstract_inverted_index":{"14646":[0],"Introduction":[1],"Ixabepilone":[2],"(BMS)":[3],"is":[4,130,264,293,301],"a":[5,14,40,82,237],"semi-synthetic":[6],"analog":[7],"of":[8,75,91,117,210,227,288],"Epothilone":[9],"B":[10],"that":[11,156],"functions":[12],"as":[13],"microtubule":[15],"stabilizer":[16],"and":[17,42,67,73,123,200,218,230,279,303,312],"has":[18],"anti-cancer":[19],"effects":[20],"in":[21,37,59,85,163,206],"several":[22],"cancers":[23],"including":[24],"renal":[25],"cell":[26,110],"carcinoma":[27],"(RCC)":[28],"(Zhuang,":[29],"ASCO":[30],"2004).":[31],"The":[32,127],"initial":[33],"phase":[34,56],"II":[35,57],"study":[36,58],"RCC":[38,60,105],"utilized":[39],"difficult":[41],"unconventional":[43],"dosing":[44],"schedule":[45,83],"(6":[46],"mg/m2":[47,94,256],"IV":[48,95,257],"days":[49],"1\u20135":[50],"every":[51,79,99,142,261],"21":[52,166],"days).":[53],"Hence,":[54],"this":[55],"was":[61],"designed":[62],"to":[63,68,146,181,244,309,321],"verify":[64],"previous":[65,118,296],"observations":[66],"test":[69],"the":[70,115,131,147,164,270,286],"safety,":[71],"feasibility,":[72],"activity":[74],"administering":[76],"BMS":[77,92],"once":[78],"3":[80,100,191,262],"weeks-":[81],"used":[84],"other":[86],"malignancies.":[87],"Methods":[88],"Treatment":[89],"consists":[90],"40":[93,255],"on":[96,114,138,250,258],"day":[97,259],"1":[98,177,223,231,260],"weeks.":[101,144],"Eligibility":[102],"included":[103],"metastatic":[104],"with":[106,176,236,269,307],"clear":[107,174],"or":[108,158],"non-clear":[109],"histology,":[111],"no":[112],"limits":[113],"number":[116],"treatments,":[119],"performance":[120],"status":[121],"0\u20132,":[122],"normal":[124],"organ":[125],"function.":[126],"primary":[128],"endpoint":[129],"overall":[132],"response":[133,226,239,308],"rate":[134],"by":[135],"RECIST":[136],"criteria":[137],"radiologic":[139],"evaluation":[140],"conducted":[141],"9":[143],"Accrual":[145,311],"full":[148],"planned":[149,302],"41":[150],"patients":[151],"(pts)":[152],"will":[153,304],"proceed":[154],"provided":[155],"2":[157],"more":[159,207],"responses":[160],"are":[161,281],"observed":[162,222],"first":[165],"pts.":[167],"Results":[168],"Ten":[169],"pts":[170,186,211,248],"have":[171,187,221],"enrolled":[172],"(4":[173],"cell)":[175],"declining":[178],"participation":[179],"prior":[180],"receiving":[182],"any":[183],"treatment.":[184,251],"Eight":[185],"completed":[188],"at":[189,254],"least":[190],"cycles.":[192],"Grade":[193,202],"3\u20134":[194],"toxicities":[195,204],"include":[196,212],"lymphopenia-2,":[197],"diarrhea-2,":[198],"alopecia-1,":[199],"infection-1.":[201],"1\u20132":[203],"seen":[205],"than":[208,266,295],"50%":[209],"alopecia,":[213],"neuropathy,":[214,278],"nausea,":[215],"fatigue,":[216],"anemia,":[217],"lymphopenia.":[219],"We":[220],"unconfirmed":[224],"partial":[225],"short":[228],"duration":[229],"pt":[232,313],"exhibited":[233],"stable":[234],"disease":[235],"minor":[238],"but":[240],"discontinued":[241],"treatment":[242],"due":[243],"excessive":[245],"neurotoxicity.":[246],"Three":[247],"continue":[249],"Conclusions":[252],"Toxicity":[253],"weeks":[263],"higher":[265,294],"previously":[267],"reported":[268],"daily":[271],"x":[272],"5":[273],"schedule.":[274],"While":[275],"lymphopenia,":[276],"diarrhea,":[277],"fatigue":[280],"all":[282,291],"expected":[283],"adverse":[284],"events,":[285],"rates":[287],"toxicity":[289],"across":[290],"grades":[292],"reports.":[297],"VHL":[298],"mutation":[299],"analysis":[300],"be":[305],"correlated":[306],"therapy.":[310],"follow":[314],"up":[315],"continue.":[316],"No":[317],"significant":[318],"financial":[319],"relationships":[320],"disclose.":[322]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}